Nalaganje...

Cross-Reactive Bactericidal Antimeningococcal Antibodies Can Be Isolated From Convalescing Invasive Meningococcal Disease Patients Using Reverse Vaccinology 2.0

The threat from invasive meningococcal disease (IMD) remains a serious source of concern despite the licensure and availability of vaccines. A limitation of current serogroup B vaccines is the breadth of coverage afforded, resulting from the capacity for extensive variation of the meningococcus and...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Front Immunol
Main Authors: Bidmos, Fadil A., Nadel, Simon, Screaton, Gavin R., Kroll, J. Simon, Langford, Paul R.
Format: Artigo
Jezik:Inglês
Izdano: Frontiers Media S.A. 2018
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6055031/
https://ncbi.nlm.nih.gov/pubmed/30061891
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2018.01621
Oznake: Označite
Brez oznak, prvi označite!